Search

everythinglearnresearchcommunity

for

Search:↓

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Cetuximab can cause excessive eyelash growth.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Finasteride effectively treats male hair loss, increasing length and thickness.

Androgens can both increase body hair and cause scalp hair loss.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New treatments for hair loss may target specific pathways and generate new hair follicles.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Topical treatments for hair loss can be effective but need careful safety evaluation.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.